Loading...
Moving treatments earlier to move further forward
In 2017, results from phase III trials demonstrated the impressive safety and efficacy of adjuvant targeted and immune therapies in patients with resectable stage III–IV melanoma, and raised questions about the surgical management of patients with microscopic sentinel-lymph-node metastases. For pati...
Na minha lista:
| Udgivet i: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436336/ https://ncbi.nlm.nih.gov/pubmed/29182162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2017.183 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|